Broad-spectrum antibiotic focusing on evidence-based approaches to minimize resistance. In humans: In veterinary medicine, co-amoxiclav, (in small animals); penicillin & streptomycin and oxytetracycline (in farm animals); penicillin and potentiated sulfonamides (in horses). Broad-spectrum antibiotic The term broad-spectrum antibiotic can refer to an antibiotic that acts on the two major bacterial groups, gram-positive and gram-negative, or any antibiotic that acts against a wide range of disease-causing bacteria. These medications are used when a bacterial infection is suspected but the group of bacteria is unknown (also called empiric therapy) or when infection with multiple groups of bacteria is suspected. This is in contrast to
Antibiotic use in livestock in its inaugural 2013 report on antibiotic resistance threats in the United States, the CDC identified resistant non-typhoidal "Salmonella" and "Campylobacter" as "serious threats" and called for improved surveillance and intervention in food production moving forward. There are other bacteria as well, where research is evolving and revealing that bacterial resistance acquired through use in livestock may be contributing to disease in humans. Examples of these include Enterococcus (including "E. coli" 0157) and "Staphylococcus aureus". For foodborne illness from "E. coli", which is still not typically treated with antibiotics because of associated risk of renal failure, increasing rates of antibiotic-resistant